Form 4: Dexcom Executive Michael Jon Brown Sells Shares Under 10b5-1 Plan
SEC Form 4
EVP and Chief Legal Officer of Dexcom, Michael Jon Brown, sold 652 shares of common stock at $69.55 per share on July 31, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On July 31, 2024, Michael Jon Brown, EVP and Chief Legal Officer of Dexcom Inc., sold 652 shares of Dexcom's common stock at a price of $69.55 per share.
- The sale was executed under a 10b5-1 trading plan adopted on December 15, 2022, and amended on August 29, 2023, allowing for the orderly disposition of shares.
- Following the transaction, Brown directly owns 66,249 shares of Dexcom common stock, which includes 60,303 unvested restricted stock units.
- These restricted stock units vest over several years, with grants made on March 8, 2022, March 8, 2023, and March 8, 2024, vesting through March 8, 2026 and March 8, 2027.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of a stock sale by an executive under a pre-arranged plan, indicating a neutral sentiment.
Industry Context
Sales by executives are a normal part of corporate governance, especially when executed under pre-arranged trading plans like 10b5-1 plans. These plans allow insiders to sell shares without being accused of trading on non-public information.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 2022-12-15 | Mr. Brown adopted a 10b5-1 Plan. |
| 2023-08-29 | Mr. Brown's 10b5-1 Plan was amended. |
| 2024-03-08 | Grant date of 21,711 unvested restricted stock units vesting through March 8, 2027. |
| 2024-03-08 | Grant date of 14,512 unvested restricted stock units vesting through March 8, 2026. |
| 2024-03-08 | Grant date of 24,080 unvested restricted stock units vesting through March 8, 2026. |
| 2024-07-31 | Date of the stock sale transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.